Search

everythinglearnresearchcommunity

for

Search:↓

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Using topical prostaglandin F2α for glaucoma may cause loss of eyelash or eyebrow pigment.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Botulinum neurotoxin injections into the pelvic muscles successfully prevented priapism relapse for over six months.

PTH-CBD agonists may help regrow hair after chemotherapy.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

FOL-005 peptide may help treat excessive hair growth safely.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The PML protein helps prevent skin cancer in mice.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.